Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Jankovic

Showing results (461-470 of 574) with videos related to

Pageof 58
Sort By:
Neurology|May 8, 2019
Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disordersTamara Pringsheim, Michael S Okun, Kirsten Müller-Vahl, et al.
Neurology|May 8, 2019
Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disordersTamara Pringsheim, Yolanda Holler-Managan, Michael S Okun, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2018
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover studyDonald L Gilbert, Tanya K Murphy, Joseph Jankovic, et al.
Neuroscience Letters|June 15, 2010
Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's diseaseMin Shi, Cyrus P Zabetian, Aneeka M Hancock, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2006
Patient selection and assessment recommendations for deep brain stimulation in Tourette syndromeJonathan W Mink, John Walkup, Kirk A Frey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2011
Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's diseaseAndrew Lees, Stanley Fahn, Karla M Eggert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 7, 2010
CSF Aβ(42) and tau in Parkinson's disease with cognitive impairmentThomas J Montine, Min Shi, Joseph F Quinn, et al.
Journal of the Neurological Sciences|February 10, 2024
Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society membersFederico Rodriguez-Porcel, Harini Sarva, Juho Joutsa, et al.
JAMA Network Open|October 5, 2021
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical TrialJoseph Jankovic, Barbara Coffey, Daniel O Claassen, et al.
Movement Disorders Clinical Practice|September 29, 2023
Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension StudyJoseph Jankovic, Barbara Coffey, Daniel O Claassen, et al.
Pageof 58

Showing results (461-470 of 574) with videos related to

Sort By:
Pageof 58
Neurology|May 8, 2019
Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disordersTamara Pringsheim, Michael S Okun, Kirsten Müller-Vahl, et al.
Neurology|May 8, 2019
Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disordersTamara Pringsheim, Yolanda Holler-Managan, Michael S Okun, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2018
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover studyDonald L Gilbert, Tanya K Murphy, Joseph Jankovic, et al.
Neuroscience Letters|June 15, 2010
Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's diseaseMin Shi, Cyrus P Zabetian, Aneeka M Hancock, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2006
Patient selection and assessment recommendations for deep brain stimulation in Tourette syndromeJonathan W Mink, John Walkup, Kirk A Frey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2011
Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's diseaseAndrew Lees, Stanley Fahn, Karla M Eggert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 7, 2010
CSF Aβ(42) and tau in Parkinson's disease with cognitive impairmentThomas J Montine, Min Shi, Joseph F Quinn, et al.
Journal of the Neurological Sciences|February 10, 2024
Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society membersFederico Rodriguez-Porcel, Harini Sarva, Juho Joutsa, et al.
JAMA Network Open|October 5, 2021
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical TrialJoseph Jankovic, Barbara Coffey, Daniel O Claassen, et al.
Movement Disorders Clinical Practice|September 29, 2023
Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension StudyJoseph Jankovic, Barbara Coffey, Daniel O Claassen, et al.
Pageof 58